Investigation of the Clinical Performance of Biatain Fiber Ag on Burns

Inclusion Criteria:

1. Has signed informed consent

2. Is between 18 -65 years (both included)

3. Is capable of following study procedure (assessed by investigator).

4. Has a partial thickness burn wound

5. Has a burn wound that is infected or at risk of infection (assessed by investigator)

6. The size of burn (including both study wound and non-study injuries) has a TotalBody Surface Area (TBSA) less than 10% (assessed by investigator).

7. The wound should fit under a 20x30 cm dressing (600 cm2) or smaller

8. The shape and location of the wound should be suitable for photo capture (assessedby the investigator).

9. Has a wound that has medium to high level of exudate (assessed by the investigator)

10. Is suitable to use the test product for wound treatment (assessed by theinvestigator).

Exclusion Criteria:

1. Is pregnant/breastfeeding

2. Is currently receiving or has within the past 60 days received radio- and/orchemotherapy (low doses radio- and/or chemotherapy is allowed for other indicationsthan cancer if assessed by investigator not to influence study wound area)

3. Known history of skin sensitivity to any components of the test dressings

4. >72 hours from time of injury

5. Intake of antibiotics within one week before the start of the enrolment

6. Use of chemical debridement

7. Participation in any other clinical studies that can compromise this study treatment (assessed by the investigator).